
    
      Three arms of treatments: A: ferric carboxymaltose and erythropoietin, B: ferric
      carboxymaltose and placebo, arm C: two placebos. Primary objective:reduction of red-cell
      packs needed for elderly patients with osteoporotic hip fracture which requires surgical
      intervention in the perioperative period.
    
  